WASHINGTON, D.C. — The U.S. Supreme Court issued rulings in 43 cases during its October 2024 term. The court heard arguments in 65 cases, with 23 cases remaining under deliberation.

The Court issued a per curiam decision in Allen v. Milligan on June 2, granting Alabama a stay. This stay permits Alabama to use its 2023 congressional map for the 2026 election, despite lower court determinations that the map is racially discriminatory.

In Federal Communications Commission v. AT&T, Inc., which was argued on April 21, the Court issued an 8-1 opinion. The Court reversed and remanded the U.S. Court of Appeals for the Fifth Circuit's decision, concluding that forfeiture orders under §503(b)(4) do not definitively resolve legal obligations. The Court also determined that the Federal Communications Commission's factual findings in forfeiture proceedings are not conclusive and ruled that the Commission's issuance of forfeiture orders without a jury does not violate the Seventh Amendment.

The Court heard arguments for Sripetch v. Securities and Exchange Commission on April 20 and issued a 9-0 decision. This decision affirmed the U.S. Court of Appeals for the Ninth Circuit, holding that a demonstration of financial loss to investors is not required before the Commission may obtain a disgorgement award.

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. was argued before the Court on April 29. The Court issued a unanimous decision, reversing and remanding the U.S. Court of Appeals for the Federal Circuit's decision. The Court determined that Amarin Pharma failed to state a claim for actively inducing infringement of its brand-name drug's patented uses and ruled that Amarin Pharma's complaint cannot withstand Hikma Pharmaceuticals' motion to dismiss.

In other judicial news, the U.S. Senate confirmed Sheria Clarke to the U.S. District Court for the District of South Carolina.